This report presents a strategic analysis of the South Korea Liver Disease Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Korea Liver Disease Drugs Market, offering unmatched value, accuracy and expert insights.
Spain neuroendocrine tumor therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. The market for neuroendocrine tumors is being driven by an increase in the number of cases of these tumors. Major global players in this market are F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Viatris Inc., Thermo Fisher Scientific Inc., Novartis AG, Regeneron Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, LUPIN, Exact Sciences Corporation, Pfizer Inc., Ipsen Pharma, Advanced Accelerator Applications (a subsidiary of Novartis AG.
Spain Complex regional pain syndrome (CRPS) Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Complex regional pain syndrome (CRPS) is expanding as a result of rising incidence of complex regional pain syndrome and the growing number of patients suffering from chronic pain and failing back syndrome. Growth in R&D spending by both commercial and public institutions, as well as favourable government legislation and increase in product launches are other factors increasing market growth. Ovid therapeutics, Astra Zeneca, Abbott, GSK, Viatris and Johnson & Johnson Services are the top key market players in Global Complex regional pain syndrome (CRPS) market.
The Hong Kong Digital Health market is projected to grow from $ 0.34Bn in 2022 to $ 1.42Bn by 2030, registering a CAGR of 19.6% during the forecast period of 2022 - 2030. The market will be driven by the innovative projects and strategies in place by the public sector and the ever-growing aging population. The market is segmented by solution, by deployment & by end-use. Some of the major players include Insilico, Longenesis & CircleDNA.
This report presents a strategic analysis of the North American blockchain Technology in the Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the North American Blockchain Technology in the Healthcare Market, offering unmatched value, accuracy, and expert insights.
This report presents a strategic analysis of the Switzerland Infectious Disease Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Switzerland Infectious Disease Drugs Market, offering unmatched value, accuracy, and expert insights.
This report presents a strategic analysis of the Switzerland Growth Hormone Deficiency Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Switzerland Growth Hormone Deficiency Clinical Trials Market, offering unmatched value, accuracy and expert insights.
South Africa Digital Therapeutics Market is at around $40 Mn in 2023 and is projected to reach $230.53 Mn in 2030, exhibiting a CAGR of 28.43 % during the forecast period. The market is growing as a result of the rising prevalence of chronic diseases, rising technology adoption, and government initiatives. The market is dominated by key players like LifeQ, Wellevate Health, Omada Health Inc., DarioHealth Corp., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and Hygieia.
This report presents a strategic analysis of the Sweden Digital Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Sweden Digital Therapeutics Market, offering unmatched value, accuracy and expert insights.
The UAE Lung Cancer Drug Market is projected to grow from $48 Mn in 2022 to $97 Mn by 2030, registering a CAGR of 9.3% during the forecast period of 2022 - 2030. According to the World Health Organization (WHO), lung cancer is the second most common cancer in both men and women in the UAE, accounting for 13% of all cancer cases. Some of the major local players in the UAE lung cancer drug market include Emirates Pharmaceutical Industries, Gulf Pharmaceutical Industries, and Julphar.
This report presents a strategic analysis of the Latin America eHealth Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Latin America eHealth Market, offering unmatched value, accuracy and expert insights.
Brazil's Electronic Health Record (EHR) market size was valued at $760 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.5% from 2022-30 and will reach $2760 Mn in 2030. Brazil's EHR market is growing as EHR can reduce the frequency of medical errors by improving the accuracy and clarity of medical records. The market is segmented by product, application, and end user. The key market players are Prosoft, Datasus, MedData, Allscripts, Cerner, and others.
This report presents a strategic analysis of the Venezuela Artificial Intelligence (AI) in Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Venezuela Artificial Intelligence (AI) in Healthcare Market, offering unmatched value, accuracy and expert insights.
UK Chronic Inflammatory Demyelinating Polyneuritis Therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. A acquired immune-mediated neuropathy that affects peripheral nerves and nerve roots, chronic inflammatory demyelinating polyneuropathy (CIDP; also known as chronic inflammatory demyelinating polyradiculoneuropathy) is characterised by a progressive or relapsing-remitting course of symmetric weakness of the proximal and distal muscles. Growing government spending and disease awareness have been the market's main drivers for Chronic Inflammatory Demyelinating Polyneuritis (CIDP) Therapeutics. Bio products laboratory Ltd., Momenta Pharmaceuticals, Grifols, Baxter, Octapharma, Shire, Kedrion SPA, Misubishi Tanabe Pharma Corporation, CSL Behring, and Teijin Pharma Ltd. are global firms in the Chronic Inflammatory Demyelinating Polyneuritis (CIDP) Therapeutics market.
Canada's Artificial Intelligence (AI) in Medical Imaging market size was valued at $120 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 35.4% from 2022 to 2030 and will reach $1356Mn. The market is segmented by AI technology, solution, modality, application, and end User. The Canada Artificial Intelligence (AI) in the Medical Imaging market will grow due to advances in AI and machine learning algorithms that are making it possible to develop more accurate and efficient medical imaging software. Some of the key players in this market are Imagia, Intelerad Medical Systems, Aifred Health, HeartForce Medical, Swift Medical, Resolution Health, Hooton AI (Vancouver, British Columbia) and others.
UK Primary Biliary Cholangitis (PBC) Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Due to a variety of critical variables, including growing public awareness of rare diseases, improving healthcare infrastructure, high disposable income, and government backing for cutting-edge autoimmune disease treatments, the market for primary biliary cholangitis treatments is booming.Major global players in Primary Biliary Cholangitis (PBC) Therapeutics Market are Actavis, Inc.; Epic Pharma, LLC; Mylan Pharmaceuticals, Inc.; Teva Pharmaceuticals; Glenmark Pharmaceuticals, Ltd.; Par Pharmaceutical, Inc.; Intercept Pharmaceuticals, Inc
This report presents a strategic analysis of the UK Vitamin and Minerals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Vitamin and Minerals Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the Morocco Digital Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Morocco Digital Therapeutics Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of Switzerland's Artificial Intelligence (AI) in the Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about Switzerland's Artificial Intelligence (AI) in the Healthcare Market, offering unmatched value, accuracy and expert insights.
In the UK, the National Health Service (NHS) provides free medical care to women, as a result, the market size of UK women’s health is predicted to witness an upsurge of about $537 Mn in 2022 with a CAGR of 5.5% and is estimated to reach $824 Mn in 2030. Growing female labour force participation, particularly in the UK, has made a substantial contribution to the market's expansion. The market is segmented by product type and by disease type. Amgen, Allergen, and Merck and Co. are some of the leading players in the women’s health market.
By 2030, it is anticipated that the US Nutrition and Supplements market will reach a value of $265.18 Bn from $160.23 Bn in 2022, growing at a CAGR of 6.5% during 2022-30. The market is primarily dominated by local players such as Amway, Herbalife Nutrition, and GNC Holdings. The market for Nutrition and supplements in the US is primarily driven by government regulations, increasing customer awareness, and e-commerce platforms. The US nutrition and supplements market in the US is segmented by Type, Product, application, and Distribution Channel.
The UAE Digital Health market is projected to grow from $1.06 Bn in 2022 to $4.42 Bn by 2030, registering a CAGR of 19.6% during the forecast period of 2022 - 2030. Driven by the COVID–19 impact generating space and requirement for digital solutions and adoption of the same by the population at large, the digital health market has exponentially grown in UAE. The market is segmented by solution, by deployment & by end–use. Some of the major players include Altibbi, Okadoc & Vezeeta.
The Kenya healthcare insurance market is projected to grow from $1.42 Bn in 2022 to $2.77 Bn by 2030, registering a CAGR of 8.7% during the forecast period of 2022 - 2030. The main factors driving the growth would be the rising population, government support, innovation and technology and increasing awareness. The market is segmented by component, the provider, coverage, by health insurance plans and end-user. Some of the major players include Jubilee Insurance, AAR Insurance, APA Insurance and UAP Old Mutual.
This report presents a strategic analysis of the Kenya Over The Counter (OTC) Drug Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Kenya Over The Counter (OTC) Drug Market, offering unmatched value, accuracy, and expert insights.
Australia Over The Counter (OTC) Drugs Market is projected to grow from $2.043 Bn in 2022 to $3.954 Bn by 2030, registering a CAGR of 8.60% during the forecast period of 2022 - 2030. The introduction of new technologies, such as digital health platforms, can also drive the OTC drug market in Australia by making it easier for consumers to access and purchase these products. There are a number of key players in the over-the-counter (OTC) drug market in Australia like Johnson & Johnson, GlaxoSmithKline, and Procter & Gamble.